Hammerhead ribozymes targeted against cy
✍
G. Grassi; A. Schneider; S. Engel; G. Racchi; R. Kandolf; A. Kuhn
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 329 KB
## Abstract ## Background Anti‐proliferative drugs released from endo‐vascular stents have substantially contributed to reduce in‐stent restenosis rates in coronary arteries bearing single primary lesions by down‐regulating coronary smooth muscle cell (CSMC) growth. However, the considerably lower